James J. Collins

Termeer Professor of Medical Engineering and Science
Broad institute of mit and harvard
The Wyss institute

James J. Collins is Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science.  He is also affiliated with the Broad Institute and the Wyss Institute.  His research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance.  Professor Collins' patented technologies have been licensed by over 25 biotech, pharma and medical devices companies, and he has helped to launched a number of companies, including Sample6 Technologies, Synlogic and EnBiotix.  He has received numerous awards and honors, including a Rhodes Scholarship, a MacArthur "Genius" Award, an NIH Director's Pioneer Award, a Sanofi-Institut Pasteur Award, as well as several teaching awards.  Professor Collins is an elected member of the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the American Academy of Arts & Sciences, and a charter fellow of the National Academy of Inventors.

He has recently published in Science, "Nucleic acid detection with CRIPSR-Cas13a/C2c2" and Cell, "Rapid, low-cost detection of Zika virus using programmable biomolecular components" and "Portable, on-demand biomolecular manufacturing".




Yu-ling cheng

Director, Center for global engineering
distinguished professor in global engineering
chemical engineering
University of toronto

Yu-Ling Cheng, is the Director of the Centre for Global Engineering, Distinguished Professor in Global Engineering, and Professor, Department of Chemical Engineering & Applied Chemistry in the Faculty of Applied Science & Engineering at the University of Toronto (UofT). She leads several global engineering research and teaching initiatives at UofT, including the Reinvent the Toilet Challenge funded by the Bill and Melinda Gates Foundation.





Walter Narajowski

partner, LAbdx l.l.c.
chairman of the board at mdxhealth (mdxh)


Walter Narajowski is a partner at LabDx l.l.c. They are strategic advisors and operational partners with Senior Management and private equity for the IVD and Laboratory Service industry. Mr. Narajowski currently serves as a chairman of the board with MDxHealth, a molecular liquid biopsy company focused in Urology. 

Previously, he was Senior Vice President and General Manager at Roka Bioscience (NASDAQ: ROKA), a molecular diagnostics company focused on improving food safety testing. Before this, Mr. Narajowski was CEO of Pathway Diagnostics, a biomarker development and testing company, which was subsequently sold to Quest Diagnostics. Prior to Pathway, Mr. Narajowski served as Vice President and General Manager of Focus Diagnostics, an infectious disease CLIA reference laboratory and diagnostic product business. The majority of Mr. Narajowski’s career was with Abbott Laboratories where he served as Vice President, General Manager of critical care products, vice president, general manager of the infusion pump business, General Manager of physician office diagnostics, and a Director of research and development. Mr. Narajowski received his MS in bioengineering from the University of Utah, and his BS in electrical engineering from the Illinois Institute of Technology.